Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
Category - Pharmaceuticals
Bayer Presents VICTOR Phase III Results for Vericiguat in Heart...
Bayer has shared new data from the VICTOR Phase III vericiguat heart failure trial in patients with...
Boehringer Ingelheim and AnGes Sign Manufacturing Agreement for...
Boehringer Ingelheim and AnGes have strengthened their long-standing collaboration with a new...
BioNTech Secures Non-Exclusive License Agreement with CureVac...
BioNTech has reached an agreement with CureVac and GSK to settle ongoing patent disputes and secure...
Alligator Bioscience Highlights Mitazalimab R&D Progress...
Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company specializing...
FluoGuide Accelerates FG001 Commercialization Through Industry...
Copenhagen, Denmark—10 August 2025 – FluoGuide A/S has released highlights from its live-recorded...
Sanofi’s rilzabrutinib earns orphan designation in the EU for...
The European Medicines Agency (EMA) has granted orphan drug designation to rilzabrutinib, Sanofi’s...
Kite to Acquire Interius BioTherapeutics to Advance In Vivo...
Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive...